Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder?
Wu X, Chen Z, Liao Y, Yang Z, Liang X, Guan N, Gan Z.
Front Psychiatry. 2023 Jan 20;13:1063479. doi: 10.3389/fpsyt.2022.1063479. eCollection 2022.
Significance of borderline personality-spectrum symptoms among adolescents with bipolar disorder.
Fonseka TM, Swampillai B, Timmins V, Scavone A, Mitchell R, Collinger KA, Goldstein BI.
J Affect Disord. 2015 Jan 1;170:39-45. doi: 10.1016/j.jad.2014.08.046. Epub 2014 Sep 3.
Experimental pain sensitivity in subjects with major depression: Many pain complaints without hypersensitivity.
Girard M, Labrunie A, Marin B, Malauzat D.
Int J Psychiatry Med. 2015;50(2):219-37. doi: 10.1177/0091217415605039. Epub 2015 Sep 7.
Clinical predictors of ketamine response in treatment-resistant major depression.
Niciu MJ, Luckenbaugh DA, Ionescu DF, Guevara S, Machado-Vieira R, Richards EM, Brutsche NE, Nolan NM, Zarate CA Jr.
J Clin Psychiatry. 2014 May;75(5):e417-23. doi: 10.4088/JCP.13m08698.
Impaired glucose metabolism moderates the course of illness in bipolar disorder.
Mansur RB, Rizzo LB, Santos CM, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni M, Cordeiro Q, McIntyre RS, Brietzke E.
J Affect Disord. 2016 May;195:57-62. doi: 10.1016/j.jad.2016.02.002. Epub 2016 Feb 4.
Clinical correlates of anhedonia and perceptual aberration in first-episode patients with schizophrenia and affective disorder.
Katsanis J, Iacono WG, Beiser M, Lacey L.
J Abnorm Psychol. 1992 Feb;101(1):184-91. doi: 10.1037//0021-843x.101.1.184.
Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial.
Richards DA, Bower P, Chew-Graham C, Gask L, Lovell K, Cape J, Pilling S, Araya R, Kessler D, Barkham M, Bland JM, Gilbody S, Green C, Lewis G, Manning C, Kontopantelis E, Hill JJ, Hughes-Morley A, Russell A.
Health Technol Assess. 2016 Feb;20(14):1-192. doi: 10.3310/hta20140.
